Covid-19 vaccine Covaxin maker Bharat Biotech on Thursday said there was no external pressure on the firm to speed up its development. In a press release, the vaccine maker said with several hundred million doses administered worldwide, Covid-19 vaccine Covaxin has demonstrated an excellent safety record with minimal adverse events and no vaccine associated cases detected for myocarditis or thrombocytopenia.